Local Institution - 0001 — New York, New York

Local Institution - 0001 is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Local Institution - 0001 has participated in 8 clinical trials with 1 currently active.

Therapeutic areas: Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Non-Hodgkin's Lymphoma.

Sponsors: Bristol-Myers Squibb, Juno Therapeutics, a Subsidiary of Celgene.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Local Institution - 0001?

Local Institution - 0001 has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Local Institution - 0001 conducted?

Local Institution - 0001 has 8 clinical trials on record, with 1 currently active. Their work covers Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Non-Hodgkin's Lymphoma.

Is Local Institution - 0001 accredited by Crixeo Health?

Yes — Local Institution - 0001 holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Local Institution - 0001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.